![]() |
市场调查报告书
商品编码
1541617
氧合器市场报告(按类型(膜氧合器、气泡氧合器)、年龄组(新生儿、儿童、成人)、应用(呼吸、心臟、体外心肺、復苏 (ECPR))和地区 2024-2032Oxygenators Market Report by Type (Membrane Oxygenator, Bubble Oxygenator), Age Group (Neonates, Pediatric, Adults), Application (Respiratory, Cardiac, Extracorporeal Cardiopulmonary, Resuscitation (ECPR)), and Region 2024-2032 |
2023年全球製氧机市场规模达2.586亿IMARC Group。
氧合器是指在医疗环境中常规使用的医疗设备,用于在外科手术过程中帮助交换患者血液中的氧气和二氧化碳。该装置与心肺机结合使用,以便在血流中断或停止的手术过程中促进气体交换。这些设备广泛用于治疗与心臟相关的疾病,例如心肺、呼吸和肺部疾病。因此,这些设备通常用于许多关键的手术,包括心肺旁路移植术 (CABG) 和冠状动脉旁路移植术 (CABG)。
全球市场的主要动力是由于大众中多种冠心病、骨科疾病和心血管疾病的盛行率不断上升,导致住院人数不断增加。这可以归因于个人久坐的生活方式,导致各种与生活方式相关的疾病以及手术介入的需求大幅增加。此外,易患这些疾病的老年人口不断增加也是市场的重要成长因素。此外,政府在医疗保健数位化、先进基础设施建设和持续产品创新方面不断增加的投资正在推动市场发展。由于医疗保健环境的改善,全球医疗机构对氧合器设备的需求和销售量显着增加。影响市场的其他一些因素包括主要参与者之间不断增加的併购 (M&A)、全球范围内严重的 COVID-19 病例的增加、各种有利的医疗保健报销倡议以及开展的广泛的研发 (R&D) 活动多个主要参与者在市场上引入先进的医疗设备。
The global oxygenators market size reached US$ 258.6 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 411.7 Million by 2032, exhibiting a growth rate (CAGR) of 5.14% during 2024-2032.
An oxygenator refers to a medical device that is routinely used in medical settings to help exchange oxygen and carbon dioxide from the patient's blood during surgical procedures. The device is used in conjunction with a heart-lung machine to facilitate gas exchange during procedures in which the blood flow is interrupted or stopped. These devices are widely used to manage heart-related disorders, such as cardiopulmonary, respiratory, and pulmonary disorders. As a result, these devices are commonly used in numerous critical surgical procedures, including cardiopulmonary bypass grafts (CABG) and coronary artery bypass grafts (CABG).
The global market is primarily driven by the growing number of hospital admissions due to the rising prevalence of numerous coronary, orthopedic and cardiovascular diseases among the masses. This can be attributed to the sedentary lifestyles led by individuals, resulting in various lifestyle-related ailments and a considerable rise in the requirement for surgical interventions. Additionally, the growing geriatric population that is susceptible to developing these diseases is also acting as a significant growth factor in the market. Additionally, the rising government investments in healthcare digitization, advanced infrastructure setup, and continual product innovations are fueling the market. As a result of improved healthcare settings, there has been a significant increase in the demand and sales for oxygenator devices across healthcare facilities on the global level. Some of the other factors contributing to the market include the increasing mergers and acquisitions (M&As) between key players, the augmenting cases of severe COVID-19 across the globe, various favorable healthcare reimbursement initiatives, and extensive research and development (R&D) activities conducted by multiple major players to introduce advanced medical devices in the market.
IMARC Group provides an analysis of the key trends in each sub-segment of the global oxygenators market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on type, age group and application.
Membrane Oxygenator
Bubble Oxygenator
Neonates
Pediatric
Adults
Respiratory
Cardiac
Extracorporeal Cardiopulmonary
Resuscitation (ECPR)
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being Braile Biomedica, Chalice Medical Ltd, Eurosets S.r.l., Getinge AB, Livanova Plc, Medtronic plc, MicroPort, Nipro Corporation, Senko Medical Instrument Mfg. Co. Ltd., Terumo Medical Corporation (Terumo Corporation) and Xenios AG (Fresenius Medical Care AG & Co. KGaA).